Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11617)
All Articles published online
|
Publishing Process of This Article
|
May 14, 2020 (publication date) through Jul 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bohra A, Worland T, Hui S, Terbah R, Farrell A, Robertson M. Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care. World J Gastroenterol 2020; 26(18): 2221-2231 [PMID: 32476788 DOI: 10.3748/wjg.v26.i18.2221] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i18/2221.htm |
| Number | Citing Articles |
| 1 |
Amera Elzubeir, Syed Munawer Alam. Letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with Rifaxamin’. World Journal of Gastroenterology 2020; 26(44): 7085-7087 doi: 10.3748/wjg.v26.i44.7085
Abstract(927) |
Core Tip(775) |
Full Article(HTML)(2512)
|
Full Article (PDF)-557K(413)
|
Full Article (Word)-35K(177)
|
Audio-702K(7)
|
Peer-Review Report-205K(181)
|
Answering Reviewers-28K(171)
|
Times Cited (0)
|
Total Visits (9514)
|
Open
|
| 2 |
Xiao Y. Tong, Michael D. Norenberg, Michael J. Paidas, Nagarajarao Shamaladevi, Luis Salgueiro, Miklos Jaszberenyi, Binu John, Hussain Hussain, Omar El hiba, El got Abdeljalil, El-Mansoury Bilal, Sampath Natarajan, Rita Romaguera, Stanislav Papayan, Arianna K. Carden, Rajalakshmi Ramamoorthy, Nila Elumalai, Andrew V. Schally, Jayakumar Nithura, Rebecca Patrizio, Arumugam R. Jayakumar. Mechanism of Alzheimer type II astrocyte development in hepatic encephalopathy. Neurochemistry International 2024; 180: 105866 doi: 10.1016/j.neuint.2024.105866
|
| 3 |
Juntao Tan, Yuxin He, Zhanbiao Li, Qinghua Zhang, Yanzhi Yang, Qian Xu, Xiaomei Xu. Analysis of the Dose-Response Relationship Between the International Normalized Ratio and Hepatic Encephalopathy in Patients With Liver Cirrhosis Using Restricted Cubic Spline Functions. Frontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.919549
|
| 4 |
Bilal El-Mansoury, Omar El Hiba, Abdelaati El Khiat, El Baz Soraia, Arumugam Radhakrishnan Jayakumar. Physiology and Function of Glial Cells in Health and Disease. Advances in Bioinformatics and Biomedical Engineering 2023; : 223 doi: 10.4018/978-1-6684-9675-6.ch012
|
| 5 |
Hideto Kawaratani, Tadashi Namisaki, Yasuteru Kondo, Ryoji Tatsumi, Naoto Kawabe, Norikazu Tanabe, Akira Sakamaki, Kyoko Hoshikawa, Yoshihito Uchida, Kei Endo, Takumi Kawaguchi, Tsunekazu Oikawa, Yoji Ishizu, Shuhei Hige, Taro Takami, Shuji Terai, Yoshiyuki Ueno, Satoshi Mochida, Kazuhiko Koike, Hitoshi Yoshiji. Real-World Setting of Efficacy and Safety of 3 Years of Rifaximin Administration in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study. Journal of Clinical Medicine 2025; 14(4): 1358 doi: 10.3390/jcm14041358
|
| 6 |
Robert S. Rahimi, Kimberly A. Brown, Steven L. Flamm, Robert S. Brown. Overt Hepatic Encephalopathy: Current Pharmacologic Treatments and Improving Clinical Outcomes. The American Journal of Medicine 2021; 134(11): 1330 doi: 10.1016/j.amjmed.2021.06.007
|
| 7 |
Anam Fatima, Faridullah Shah, Hareema Saeed Khan, Kashif Rauf, Asif Jalil, Muhammad Saleem Akhter. Association Of Electroencephalogram Patterns With Ammonia Levels In Hepatic Encephalopathy Patients. Journal of Rawalpindi Medical College 2023; 27(3) doi: 10.37939/jrmc.v27i3.2041
|
| 8 |
Adam P. Buckholz, Robert S. Brown. Future Therapies of Hepatic Encephalopathy. Clinics in Liver Disease 2024; 28(2): 331 doi: 10.1016/j.cld.2024.02.002
|
| 9 |
Hong Yang, Jing Tian, Bingxia Meng, Ke Wang, Chu Zheng, Yanling Liu, Jingjing Yan, Qinghua Han, Yanbo Zhang. Application of Extreme Learning Machine in the Survival Analysis of Chronic Heart Failure Patients With High Percentage of Censored Survival Time. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.726516
|
| 10 |
Mithun Sharma, Manasa Alla, Anand Kulkarni, Padaki Nagaraja Rao, Duvvur Nageshwar Reddy. Managing a Prospective Liver Transplant Recipient on the Waiting List. Journal of Clinical and Experimental Hepatology 2024; 14(1): 101203 doi: 10.1016/j.jceh.2023.06.003
|
| 11 |
Rehab Nady, Rasha R. Ahmed, Nadia Moustafa, Manal Abdul-Hamid. TNF-α blockage by etanercept restores spatial learning and reduces cellular degeneration in the hippocampus during liver cirrhosis. Tissue and Cell 2023; 85: 102249 doi: 10.1016/j.tice.2023.102249
|
| 12 |
Surbhi Trivedi, Katie Lam, Ashwin Ganesh, Yasir Hasnain, Wassim Hassan, Josi Herren, Ron C. Gaba. Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation. Seminars in Interventional Radiology 2023; 40(01): 009 doi: 10.1055/s-0043-1764282
|
| 13 |
Axel Holstege. Hepatische Enzephalopathie Teil 1: Definitionen, Pathogenese und Diagnostik. Gastroenterologie up2date 2023; 19(03): 241 doi: 10.1055/a-1984-7039
|
| 14 |
Steven L. Flamm. Key Insights and Clinical Pearls in the Identification and Management of Cirrhosis and Its Complications. The American Journal of Medicine 2024; 137(10): 929 doi: 10.1016/j.amjmed.2024.05.015
|
| 15 |
Harry D Zacharias, Fady Kamel, Jaclyn Tan, Nina Kimer, Lise Lotte Gluud, Marsha Y Morgan. Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database of Systematic Reviews 2023; 2023(7) doi: 10.1002/14651858.CD011585.pub2
|
| 16 |
Tania Payo‐Serafín, Carolina Méndez‐Blanco, Paula Fernández‐Palanca, Jennifer Martínez‐Geijo, María Reviejo, Juan José Ortiz‐de‐Urbina, Javier González‐Gallego, Jose J. G. Marin, José L. Mauriz, Beatriz San‐Miguel. Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Clinical Pharmacology & Therapeutics 2024; 116(2): 328 doi: 10.1002/cpt.3312
|
| 17 |
Chien-Hao Huang, Hsiao-Jung Tseng, Piero Amodio, Yu-Ling Chen, Sheng-Fu Wang, Shang-Hung Chang, Sen-Yung Hsieh, Chun-Yen Lin. Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis Improve Cirrhosis Outcome Prediction: A Modified Seven-Stage Model as a Clinical Alternative to MELD. Journal of Personalized Medicine 2020; 10(4): 186 doi: 10.3390/jpm10040186
|
| 18 |
William S.A. Brusilow. Saul Brusilow: Understanding and treating diseases of ammonia toxicity. Analytical Biochemistry 2022; 636: 114478 doi: 10.1016/j.ab.2021.114478
|
| 19 |
Lucia Lapenna, Simone Di Cola, Manuela Merli. The crucial role of risk factors when dealing with hepatic Encephalopathy. Metabolic Brain Disease 2024; 40(1) doi: 10.1007/s11011-024-01446-0
|
| 20 |
Aalam Sohal, Victoria Green, Sunny Sandhu, Marina Roytman. Identifying areas of improvement in nursing knowledge regarding hepatic encephalopathy management. Journal of Community Hospital Internal Medicine Perspectives 2021; 11(5): 722 doi: 10.1080/20009666.2021.1954784
|
| 21 |
Juan Li, Chan Li, Jie Zou, Fang-Qun Cheng, Li Peng, Li-Hong Deng, Pei-Pei Wu, Sai-Yu Gao, Zhi-Yao Xiong, Ying Zuo, Yan Luo, Xiao-Hua Rao, Bo Yuan, Ou-Ying Chen, Jing-Ping Zhang. Prevalence and influencing factors of the dyadic psychological stress among patients with lung cancer and their family caregivers: a cross-sectional study. BMC Nursing 2025; 24(1) doi: 10.1186/s12912-024-02635-z
|
| 22 |
Yizhen Tian, Weihu Yang, Ruiying Yang, Qingqing Zhang, Luyang Hao, Enze Bian, Yuquan Yang, Xuewei Huang, Yongjie Wu, Baolai Zhang. Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5. Toxicology and Applied Pharmacology 2022; 435: 115829 doi: 10.1016/j.taap.2021.115829
|
| 23 |
Yu Jun Wong, Jing Hong Loo. Albumin therapy for hepatic encephalopathy: current evidence and controversies. Metabolic Brain Disease 2023; 38(5): 1759 doi: 10.1007/s11011-022-01002-8
|
| 24 |
Richard J Aspinall, Mark Hudson, Stephen D Ryder, Paul Richardson, Elizabeth Farrington, Mark Wright, Robert T Przemioslo, Francisco Perez, Melanie Kent, Roland Henrar, Joe Hickey, Debbie L Shawcross. Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II). Frontline Gastroenterology 2023; 14(3): 228 doi: 10.1136/flgastro-2022-102221
|
| 25 |
Yevedzo Ntuli, Debbie L. Shawcross. Infection, inflammation and hepatic encephalopathy from a clinical perspective. Metabolic Brain Disease 2024; 39(8): 1689 doi: 10.1007/s11011-024-01402-y
|
| 26 |
Yevedzo Ntuli, Chiara Mangini, Thomas Henry Tranah, Victoria T Kronsten, Sara Montagnese, Debbie L Shawcross. Hepatic encephalopathy: Part 1, a diagnostic approach. Frontline Gastroenterology 2025; : flgastro-2025-103135 doi: 10.1136/flgastro-2025-103135
|
| 27 |
Yeniffer Bermúdez, Sandra Neri, Cesar Morao, Ana López, Dayana Lombano, Genesis Rojas, Milagros Miquilena, Yauribel Martínez, Ayerim Higuera. Impacto de la desnutrición y sarcopenia en pacientes pediátricos con cirrosis hepática. Revista GEN 2024; 78(1): 11 doi: 10.61155/2024.78.1.003
|
| 28 |
Hoor Al Kaabi, Abdullah M. Al Alawi, Zubaida Al Falahi, Zakariya Al-Naamani, Said A. Al Busafi. Clinical Characteristics, Etiology, and Prognostic Scores in Patients with Acute Decompensated Liver Cirrhosis. Journal of Clinical Medicine 2023; 12(17): 5756 doi: 10.3390/jcm12175756
|
| 29 |
Lívia Guimarães, Juliana Piedade, Joana Duarte, Caroline Baldin, Lívia Victor, Barbara Costa, Zulane Veiga, Camila Alcântara, Flávia Fernandes, Gustavo Pereira. Hepatic Encephalopathy in Cirrhotic Patients With Bacterial Infections: Frequency, Clinical Characteristics, and Prognostic Relevance. Journal of Clinical and Experimental Hepatology 2023; 13(4): 559 doi: 10.1016/j.jceh.2023.01.004
|
| 30 |
Ahmed T Algahiny, Hosam Alazazzi, Zain Sharif, Niloy Sil, Yasir A Zaidi, Farhad R Mashori, Bawan Ali, Aemon F Jaffery, Omar HE Abouelella, Udoy Sil, Muneeb Ullah. Evaluating Clinical Outcomes of Adjunct Rifaximin Therapy in Patients with Overt Hepatic Encephalopathy: A Prospective Randomized Study. Euroasian journal of hepato-gastroenterology 2025; 15(1): 58 doi: 10.5005/jp-journals-10018-1473
|